THE ECONOMICS AND COST-EFFECTIVENESS OF CRITICAL CARE MEDICINE

被引：109
作者：
CHALFIN, DB
COHEN, IL
LAMBRINOS, J
机构：
[1] BUFFALO GEN HOSP,SURG INTENS CARE UNIT,BUFFALO,NY 14203
[2] UNION COLL,GRAD MANAGEMENT INST,SCHENECTADY,NY 12308
来源：
INTENSIVE CARE MEDICINE | 1995年 / 21卷 / 11期
关键词：
D O I：
10.1007/BF01712339
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
[No abstract available]
引用
收藏
页码：952 / 961
页数：10
相关论文
共 64 条
[1]  
ASHBY JL, 1993, INQUIRY, V20, P362
[2]  
BAMS JL, 1985, INTENS CARE MED, V11, P234
[3]  
BERENSON RA, 1984, CLIN OUTCOMES COSTS
[4]   COST-CONTAINMENT IN CRITICAL CARE [J].
BIRNBAUM, ML .
CRITICAL CARE MEDICINE, 1986, 14 (12) :1068-1077
[5]   SEPSIS SYNDROME - A VALID CLINICAL ENTITY [J].
BONE, RC ;
FISHER, CJ ;
CLEMMER, TP ;
SLOTMAN, GJ ;
METZ, CA ;
BALK, RA .
CRITICAL CARE MEDICINE, 1989, 17 (05) :389-393
[6]  
Chalfin D B, 1994, New Horiz, V2, P275
[7]   THE ECONOMIC-IMPACT AND COST-EFFECTIVENESS OF MONOCLONAL-ANTIBODY THERAPY FOR SEPSIS [J].
CHALFIN, DB ;
FEIN, AM .
CLINICAL INFECTIOUS DISEASES, 1993, 17 :S520-S524
[8]   COST-EFFECTIVENESS OF MONOCLONAL-ANTIBODIES TO GRAM-NEGATIVE ENDOTOXIN IN THE TREATMENT OF GRAM-NEGATIVE SEPSIS IN ICU PATIENTS [J].
CHALFIN, DB ;
HOLBEIN, MEB ;
FEIN, AM ;
CARLON, GC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (02) :249-254
[9]  
Chang RWS, 1993, CLIN INTENSIVE CARE, V4, P208
[10]  
CHASSIN M, 1982, MED CARE, V2, P1282
1234567